Genetics On the Forefront of New Cystic Fibrosis Treatment
Molecular medicine
There are also additional CFTR specific mutations that have and are being targeted using molecular medicine. As anyone can see, the potential benefit here is huge. This type of medicine would mean that patients have the option to actually target the sources of their disease, rather than just dealing with the symptoms after they appear.
